Status:
COMPLETED
Chlorhexidine Mouthrinses and Plaque Control
Lead Sponsor:
Hôpital Militaire De Rabat
Collaborating Sponsors:
CCTD, Centre Hospitalier Ibn Sina,Morocco
Faculté de Médecine Dentaire de Rabat
Conditions:
Dental Plaque
Eligibility:
All Genders
20-25 years
Phase:
NA
Brief Summary
The aim of the present study was to compare antiplaque effectiveness of two commercial mouthrinses: 0.12 % Chlorhexidine alcohol base (CLX-A) versus a diluted 0.1% Chlorhexidine non-alcohol base with ...
Detailed Description
Chlorhexidine (CLX) mouthrinse has been the gold standard as antiplaque solution.However, if its efficiency seems to be preserved even if the chlorhexidine concentration is bellow 0.10%, the formulati...
Eligibility Criteria
Inclusion
- give written informed consent before entering the study
- accept to stop tooth cleaning for a week
Exclusion
- less than 20 teeth;
- presence of periodontal disease
- presence of factors of plaque retention (clinically unacceptable restorations, important carious, dental overlapping, removable prosthesis, faulty fixed prosthesis, orthodontic appliances),
- associated systemic diseases (diabetes, heart disorders, blood diseases, HIV infection),
- use of antibiotics or other anti-inflammatory drugs during the latest months,
- known allergy against components of mouth rinses,
- pregnancy,
- smoking
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01138943
Start Date
February 1 2007
End Date
April 1 2007
Last Update
May 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculté de Médecine Dentaire
Rabat, Morocco, 10 000